Pa Shun International Holdings Ltd
HKEX:574
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pa Shun International Holdings Ltd
Revenue
Pa Shun International Holdings Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pa Shun International Holdings Ltd
HKEX:574
|
Revenue
¥86.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Wanjia Group Holdings Ltd
HKEX:401
|
Revenue
HK$163.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
China Health Group Ltd
HKEX:673
|
Revenue
HK$39.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
T
|
Tai United Holdings Ltd
HKEX:718
|
Revenue
HK$125.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Y
|
Yunnan Energy International Co Ltd
HKEX:1298
|
Revenue
HK$392.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
45%
|
CAGR 10-Years
-11%
|
|
|
T
|
Tycoon Group Holdings Ltd
HKEX:3390
|
Revenue
HK$1.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Pa Shun International Holdings Ltd
Glance View
Pa Shun International Holdings Ltd. engages in the manufacture and distribution of pharmaceutical products. The firm operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.
See Also
What is Pa Shun International Holdings Ltd's Revenue?
Revenue
86.8m
CNY
Based on the financial report for Dec 31, 2025, Pa Shun International Holdings Ltd's Revenue amounts to 86.8m CNY.
What is Pa Shun International Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
-29%
Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Pa Shun International Holdings Ltd have been 7% over the past three years , -29% over the past five years .
